CARASENT ASA NK 1332
Carasent ASA provides cloud based electronic health record solutions to the health care industry in Sweden, Norway, and internationally. The company offers Webdoc, a cloud-based EHR system; Metodika EPM, a solution designed for mid-to-large-sized organizations; Medrave M4 to give healthcare staff and managers an overview and clear picture of the patient group being treated; Health Profile Institu… Read more
Market Cap & Net Worth: CARASENT ASA NK 1332 (C34)
CARASENT ASA NK 1332 (F:C34) has a market capitalization of $129.18 Million (€125.85 Million) as of March 18, 2026. Listed on the F stock exchange, this Germany-based company holds position #17911 globally and #1873 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CARASENT ASA NK 1332's stock price €1.74 by its total outstanding shares 72324800 (72.32 Million).
CARASENT ASA NK 1332 Market Cap History: 2020 to 2024
CARASENT ASA NK 1332's market capitalization history from 2020 to 2024. Data shows change from $256.87 Million to $129.18 Million (-4.81% CAGR).
CARASENT ASA NK 1332 Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CARASENT ASA NK 1332's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of C34 by Market Capitalization
Companies near CARASENT ASA NK 1332 in the global market cap rankings as of March 18, 2026.
Key companies related to CARASENT ASA NK 1332 by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #724 globally with a market cap of $28.17 Billion USD.
- BrightSpring Health Services, Inc. Tangible Equity Unit (NASDAQ:BTSGU): Ranked #989 globally with a market cap of $19.86 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2240 globally with a market cap of $6.77 Billion USD.
- HealthEquity Inc (NASDAQ:HQY): Ranked #2273 globally with a market cap of $6.65 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #724 | Veeva Systems Inc Class A | NYSE:VEEV | $28.17 Billion | $186.70 |
| #989 | BrightSpring Health Services, Inc. Tangible Equity Unit | NASDAQ:BTSGU | $19.86 Billion | $139.72 |
| #2240 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $6.77 Billion | $42.10 |
| #2273 | HealthEquity Inc | NASDAQ:HQY | $6.65 Billion | $79.40 |
CARASENT ASA NK 1332 Historical Marketcap From 2020 to 2024
Between 2020 and today, CARASENT ASA NK 1332's market cap moved from $256.87 Million to $ 129.18 Million, with a yearly change of -4.81%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2024 | €129.18 Million | +79.57% |
| 2023 | €71.94 Million | -34.44% |
| 2022 | €109.73 Million | -59.84% |
| 2021 | €273.20 Million | +6.36% |
| 2020 | €256.87 Million | -- |
End of Day Market Cap According to Different Sources
On Dec 3rd, 2025 the market cap of CARASENT ASA NK 1332 was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $129.18 Million USD |
| MoneyControl | $129.18 Million USD |
| MarketWatch | $129.18 Million USD |
| marketcap.company | $129.18 Million USD |
| Reuters | $129.18 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.